English
DOI:
https://doi.org/10.1590/s2175-97902022e20741Palavras-chave:
Tuberculosis, COVID-19, PandemicResumo
Recently, the world has coped with the challenge of the novel SARS-CoV-2 rapid spreading, causing COVID-19. This scenario has overburdened health systems, forced social isolation, and interrupted some services, changing the way how health assistance is provided. The management of chronic infectious diseases such as tuberculosis is a sensitive matter in times when the control strategies are at risk. In this sense, how could a high burden disease such as tuberculosis affect or be affected when combined with the COVID-19 pandemic? Patients with tuberculosis have a social background and lung impairment that represent risks in the pandemic scenario of another widely transmitted respiratory disease. Thus, even with several questions remaining unanswered, research and public policies should be addressed to control the effects of the current highly contagious COVID-19 without forgetting how it will affect the natural progression of patients suffering from tuberculosis.
Downloads
Referências
Ahmed SAKS, Ajisola M, Azeem K, Bakibinga P, Chen Y-F, Choudhury NN, et al. Impact of the societal response to COVID-19 on access to healthcare for non-COVID-19 health issues in slum communities of Bangladesh, Kenya, Nigeria and Pakistan: results of pre-COVID and COVID-19 lockdown stakeholder engagements. BMJ Glob Heal 2020;5(8):e003042. https://doi.org/10.1136/bmjgh-2020-003042.
» https://doi.org/https://doi.org/10.1136/bmjgh-2020-003042
Alagna R, Besozzi G, Codecasa LR, Gori A, Migliori GB, Raviglione M, et al. Celebrating World Tuberculosis Day at the time of COVID-19. Eur Respir J. 2020;55(4)2000650. https://doi.org/10.1183/13993003.00650-2020.
» https://doi.org/https://doi.org/10.1183/13993003.00650-2020
Belicchi-Ferrari M, Bisceglie F, Buschini A, Franzoni S, Pelosi G, Pinelli S, et al. Synthesis, structural characterization and antiproliferative and toxic bio-activities of copper(II) and nickel(II) citronellal N4-ethylmorpholine thiosemicarbazonates. J Inorg Biochem. 2010;104(2):199-206. https://doi.org/10.1016/j.jinorgbio.2009.11.002.
» https://doi.org/https://doi.org/10.1016/j.jinorgbio.2009.11.002
Datta S, Evans CA. Healthy survival after tuberculosis. Lancet Infect Dis. 2019;19(10):1045-7. https://doi.org/10.1016/ S1473-3099(19)30387-1.
» https://doi.org/https://doi.org/10.1016/ S1473-3099(19)30387-1
Liu Y, Bi L, Chen Y, Wang Y, Fleming J, Yu Y, et al. Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity. MedRxiv. 2020:2020.03.10.20033795. https://doi.org/10.1101/2020.03.10.20033795.
» https://doi.org/https://doi.org/10.1101/2020.03.10.20033795
Louie JK, Reid M, Stella J, Agraz-Lara R, Graves S, Chen L, et al. A decrease in tuberculosis evaluations and diagnoses during the COVID-19 pandemic. Int J Tuberc Lung Dis. 2020;24(8):860-2.
Maheshwari N, Jain A. Is There a Rationale for Using Bacillus Calmette-Guerin Vaccine in Coronavirus Infection? Viral Immunol 2020;00:1-7. https://doi.org/10.1089/vim.2020.0079.
» https://doi.org/https://doi.org/10.1089/vim.2020.0079
Miller A, Reandelar MJ, Fasciglione K, Roumenova V, Li Y, Otazu GH. Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study. medRxiv 2020; Preprint https://doi.org/10.1101/2020.03.24.20042937.
» https://doi.org/https://doi.org/10.1101/2020.03.24.20042937
Motta I, Centis R, D’Ambrosio L, García-García JM, Goletti D, Gualano G, et al. Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonology. 2020;26:233-40. https://doi.org/10.1016/j.pulmoe.2020.05.002.
» https://doi.org/https://doi.org/10.1016/j.pulmoe.2020.05.002
Ong CWM, Migliori GB, Raviglione M, MacGregor-Skinner G, Sotgiu G, Alffenaar JW, et al. Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC). Eur Respir J 2020;56. https://doi.org/10.1183/13993003.01727-2020.
» https://doi.org/https://doi.org/10.1183/13993003.01727-2020
Saunders MJ, Evans CA. COVID-19, tuberculosis and poverty: preventing a perfect storm. Eur Respir J . 2020;56(1):2001348. https://doi.org/10.1183/13993003.01348-2020.
» https://doi.org/https://doi.org/10.1183/13993003.01348-2020
Sy KTL, Haw NJL, Uy J. Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19. Infect Dis (Auckl). 2020;52(12):902-7. https://doi.org/10.1080/23744235.2020.1806353.
» https://doi.org/https://doi.org/10.1080/23744235.2020.1806353
Tadolini M, Codecasa LR, García-García JM, Blanc FX, Borisov S, Alffenaar JW, et al. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J . 2020;56(1):2001398. https://doi.org/10.1183/13993003.01398-2020.
» https://doi.org/https://doi.org/10.1183/13993003.01398-2020
World Health Organization. Note: Tuberculosis and COVID-19. 2020.
World Health Organization. Global Tuberculosis Report. 2019.
World Health Organization. Global tuberculosis report. Geneva, Switzerland: 2018.
World Health Organization. Implementing tuberculosis diagnostics: A policy framework 2015:39. https://doi.org/WHO/HTM/TB/2015.11.
» https://doi.org/https://doi.org/WHO/HTM/TB/2015.11
Yitbarek K, Abraham G, Girma T, Tilahun T, Woldie M. The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing sever infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic. Vaccine 2020;38($1):6374-80. https://doi.org/10.1016/j.vaccine.2020.08.018.
» https://doi.org/https://doi.org/10.1016/j.vaccine.2020.08.018
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
